
B3 is a zzso zzso zzso zzso that recognizes a zzso zzso zzso present on the surface of many zzso An imaging and Phase I trial was performed to study the ability of zzso B3 to image known zzso and determine the maximum tolerated dose zzso zzso toxicity zzso zzso and zzso of zzso zzso Patients zzso zzso 26) with advanced zzso tumors that express the zzso zzso were zzso All patients received 5 zzso of zzso B3 for zzso zzso B3 doses were escalated from 5 to 25 zzso in zzso zzso zzso B3 and zzso B3 were zzso over a zzso zzso zzso tumor imaging was observed in 20 of 26 zzso Sites zzso included zzso liver, bone, and soft zzso The zzso of zzso B3 was determined to be 20 zzso The zzso were zzso and zzso zzso doses ranged from zzso to zzso zzso zzso and zzso B3 serum zzso zzso zzso zzso were found to be zzso The amount of B3 administered zzso 10, and 50 zzso did not alter the zzso Bone zzso zzso zzso zzso zzso showed zzso of injected zzso for zzso B3 compared to zzso of injected zzso for zzso B3 zzso zzso zzso When given to patients with zzso that express the zzso zzso zzso B3 demonstrated good tumor zzso The zzso of zzso B3 is 20 zzso with zzso as the zzso Higher doses of zzso need to be delivered to achieve an zzso zzso zzso zzso B3 is being developed for evaluation in zzso A clinical trial to explore the use of higher doses of zzso B3 with zzso stem cell support is zzso 

